好体育-好体育全站app|好体育全站app官网入口

Periodical
CURRENT LOCATION: HOME > Investor Relations > Periodical
Periodical

好体育全站app官网入口2013年年度报告

2014.03.31

好体育全站app官网入口2013年第三季度报告

2013.10.31

好体育全站app官网入口2013年半年度报告

2013.08.30

好体育全站app官网入口2013年第一季度报告

2013.04.30
  •  
  • 1
  • 2
  • 3
  • 4
  • 5
  •  

    • CURRENT LOCATION:

    HOME > Investor Relations> Periodical
    About Us
    Group Introduction
    Management Team
    Development Strategy
    Corporate Culture
    Milestones
    Contact Us
    News
    News
    Global
    Global Layout
    Asia
    North America
    Africa
    Europe
    Products
    API
    Preparation
    R&D and Innovation
    Overview
    R&D Centers
    Development Progress
    Technology Platform
    Introduction To Key Projects
    Partnership
    We Seek
    We Offer
    Investor Relations
    Corporate Governance
    Financial Highlight
    Periodical
    Ad-hoc
    Investor Interaction

    COPYRIGHT 2024 HUMANWELL GROUP ALL RIGHTS RESERVED.

    Privacy protection Legal statement
    Technical Support: Lucky xp
    Group Subsidiary GROUP SUBSIDIARY
    Yichang Humanwell Pharmaceutical Co., Ltd Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Wuhan Humanwell Pharmaceutical Co., Ltd Xinjiang Uyghur Pharmaceutical Co., Ltd. Humanwell Puke Pharmaceutical (Wuhan) Co., Ltd Yichang Sanxia Pharmaceutical Co., Ltd Epic Pharma, LLC Beijing Baron Medical Equipment Co., Ltd. Wuhan Tianrun Health Products Co., Ltd.
    QRCode
    Group Subsidiary GROUP SUBSIDIARY
    Yichang Humanwell Pharmaceutical Co., Ltd Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Wuhan Humanwell Pharmaceutical Co., Ltd Xinjiang Uyghur Pharmaceutical Co., Ltd. Humanwell Puke Pharmaceutical (Wuhan) Co., Ltd Yichang Sanxia Pharmaceutical Co., Ltd Epic Pharma, LLC Beijing Baron Medical Equipment Co., Ltd. Wuhan Tianrun Health Products Co., Ltd.
    QRCode

    COPYRIGHT 2024 HUMANWELL GROUP ALL RIGHTS RESERVED.

    Privacy protection Legal statement
    Technical Support: Lucky xp